T. Rowe Price Associates
FURX

T. Rowe Price Associates’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

T. Rowe Price Associates’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-5,118
Closed -$543K – 2609
2014
Q2 		$543K Hold
5,118
– – ﹤0.01% 1915
2014
Q1 		$445K Sell
5,118
-800
-14% -$61.8K ﹤0.01% 1967
2013
Q4 		$249K Sell
5,918
-3,800
-39% -$156K ﹤0.01% 2234
2013
Q3 		$427K Sell
9,718
-2,100
-18% -$86.9K ﹤0.01% 1953
2013
Q2 		$403K Buy
+11,818
New +$415K ﹤0.01% 1952

T. Rowe Price Associates's FURX Position: Q3 2014 in Review

T. Rowe Price Associates sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 5,118 shares — an estimated $543K sold.

T. Rowe Price Associates first reported a position in FURX in Q2 2013 and held it in 5 quarters. The position peaked at $543K in Q2 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

  • T. Rowe Price Associates reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • T. Rowe Price Associates sold 5,118 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $543K.
  • T. Rowe Price Associates first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 5 quarters.
  • T. Rowe Price Associates's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $543K in Q2 2014.
  • 0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on T. Rowe Price Associates's 13F filing for Q3 2014, filed 14 Nov 2014.